Biotron Limited filed its Annual on Aug 19, 2022 for the period ending Jun 30, 2022. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.034 AUD | -2.86% |
|
-12.82% | -64.95% |
06-19 | Biotron's HIV Therapy Meets Primary Endpoints in Phase Two Trial; Shares Rally 15% | MT |
04-05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
1st Jan change | Capi. | |
---|---|---|
-64.95% | 21.4M | |
+21.40% | 127B | |
+24.87% | 117B | |
+26.35% | 27.67B | |
-18.90% | 20.33B | |
-15.59% | 16.79B | |
-18.03% | 15.63B | |
+13.27% | 14.84B | |
-47.70% | 14.65B | |
+57.30% | 14.43B |
- Stock Market
- Equities
- BIT Stock
- News Biotron Limited
- Biotron Limited Auditor Raises 'Going Concern' Doubt